A Ludwig Cancer Research study has identified a novel mechanism by which a type of cancer immunotherapy known as CTLA-4 blockade can disable suppressive immune cells to aid the destruction of certain tumors. The tumors in question are relatively less ...
from Google Alert - health https://ift.tt/2ZxVcY5
via IFTTT
0 comments:
Post a Comment